Surgical Treatment of Hydatid Liver Disease
Condition: Hydatid Cyst, Hepatic Intervention: Sponsor: University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Accurate Point of Care Liver Disease Diagnostics
Conditions: NAFLD; Nonalcoholic Fatty Liver Interventions: Diagnostic Test: Liverscope® exam; Diagnostic Test: MR exam; Diagnostic Test: FibroScan® exam (optional); Other: Blood draw; Other: Body measurements; Other: Questionnaires Sponsors: University of California, San Diego; Livivos, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Surgical Treatment of Hydatid Liver Disease
Condition: Hydatid Cyst, Hepatic Intervention: Sponsor: University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trial
DiscussionWe anticipate that this project will lead to improved prognostication of patients with cirrhosis, in terms of their peri-procedural bleeding risk. We hope to show that a significant proportion of cirrhotic patients, deemed coagulopathic on the basis of standard coagulation tests such as INR and platelet count, are actually in a haemostatic balance and thus do not require prophylactic blood product, leading to decreased and more efficient blood component use.Trial registrationRECIPE has been prospectively registered with the Australia and New Zealand Clinical Trials Registry on the 30th April 2019 (ACTRN1261900...
Source: Trials - August 11, 2023 Category: Research Source Type: clinical trials
Accurate Point of Care Liver Disease Diagnostics
Conditions: NAFLD; Nonalcoholic Fatty Liver Interventions: Diagnostic Test: Liverscope® exam; Diagnostic Test: MR exam; Diagnostic Test: FibroScan® exam (optional); Other: Blood draw; Other: Body measurements; Other: Questionnaires Sponsors: University of California, San Diego; Livivos, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
Dose-response Association Between hsCAR and MAFLD: A Cross-sectional Study
Conditions: Metabolic Dysfunction-associated Fatty Liver Disease; Hepatic Steatosis; Liver Fibrosis Intervention: Other: high-sensitivity C-reactive protein to albumin ratio Sponsor: Chongqing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials
